Check out our most popular compounded medications! Get Started
The Triazolam 0.25 mg/5 mL Oral Liquid is a specially crafted medication designed for oral use, offering a precise and manageable method for administering the prescribed dose of Triazolam. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills or tablets, making it an ideal choice for pediatric and geriatric patients. Triazolam is commonly used in the treatment of insomnia, characterized by difficulty falling asleep or staying asleep, and may also be employed for sedation before medical procedures. The liquid form ensures that the medication can be easily measured and ingested.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Triazolam 0.25 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, providing a precise 0.25 mg dose of triazolam in every 5 mL of liquid. This formulation is particularly beneficial for patients who have difficulty swallowing pills, such as those in pediatric or geriatric populations, or for individuals with dysphagia or other conditions that impair the ability to ingest solid forms of medication. The liquid form ensures ease of administration and allows for flexible dosing, which can be adjusted according to the specific needs of the patient.
Triazolam is a benzodiazepine that is commonly prescribed for the short-term treatment of insomnia. It works by enhancing the effects of GABA, a neurotransmitter in the brain that induces sedation, reduces anxiety, and facilitates sleep. However, due to its potential for dependence and tolerance, triazolam is typically prescribed for short durations, usually not exceeding two weeks.
Patients and prescribers should be aware that triazolam can cause side effects such as drowsiness, dizziness, and coordination problems, which may impair the ability to perform tasks that require alertness, such as driving. It is also important to avoid alcohol and other CNS depressants while taking this medication. Prescribers should thoroughly assess the patient's medical history, including any history of substance abuse, before initiating treatment with triazolam. Additionally, gradual tapering of the dose may be necessary to avoid withdrawal symptoms when discontinuing the medication.
Our team at Bayview Pharmacy is committed to providing high-quality, customized medications to meet the unique needs of each patient. We are available to answer any questions or concerns regarding the formulation, administration, or effects of Triazolam 0.25 mg/5 mL Oral Liquid. If you require further information or guidance, please do not hesitate to reach out to us for professional assistance.
Triazolam is a short-acting benzodiazepine commonly prescribed for the treatment of insomnia. It works by enhancing the effects of GABA, a neurotransmitter that induces sedation and relaxation. When considering the use of triazolam in a 0.25 mg/5 mL oral liquid formulation, it is crucial to be aware of potential drug interactions that may affect the efficacy and safety of the medication.
Triazolam should not be used in conjunction with alcohol or other central nervous system depressants, as these can significantly increase the sedative effects, leading to excessive drowsiness, respiratory depression, and potentially life-threatening situations. Caution is also advised when triazolam is taken with other medications that can cause drowsiness, such as antihistamines, some antidepressants, antipsychotics, and opioid analgesics.
Concomitant use of triazolam with inhibitors of the CYP3A4 enzyme, such as ketoconazole, itraconazole, nefazodone, fluvoxamine, and cimetidine, can lead to increased plasma levels of triazolam, resulting in enhanced pharmacological effects and a higher risk of adverse reactions. Conversely, CYP3A4 inducers like rifampin, carbamazepine, and St. John's Wort can decrease triazolam plasma levels, potentially reducing its efficacy.
Caution is also warranted when triazolam is used with certain antibiotics like clarithromycin and erythromycin, as these can inhibit the metabolism of triazolam, leading to increased effects. Grapefruit juice, which can also inhibit CYP3A4, should be avoided as it can similarly increase the levels of triazolam in the blood.
Patients taking oral contraceptives or medications for HIV/AIDS, such as protease inhibitors, should be monitored closely as these can also affect the metabolism of triazolam. Additionally, the anticoagulant effects of warfarin may be altered when taken with triazolam, necessitating careful monitoring of prothrombin time or INR.
It is important for patients to inform their healthcare provider of all medications, supplements, and herbal products they are currently taking before starting triazolam to avoid potential drug interactions. Prescribers should review the patient's medication history to assess for possible interactions and adjust the triazolam dose accordingly or consider alternative treatments if necessary.
Patients should be counseled on the signs and symptoms of excessive sedation, respiratory depression, and other serious side effects. They should be instructed to contact their healthcare provider immediately if they experience any concerning reactions. If you have any questions or require further information regarding triazolam interactions, please reach out to us at Bayview Pharmacy for assistance.
The Triazolam 0.25 mg/5 mL Oral Liquid is a specially compounded medication designed for ease of administration and precise dosing. Triazolam, the active ingredient in this formulation, is a benzodiazepine that works by enhancing the activity of neurotransmitters in the brain to produce a calming effect. It is commonly used for the short-term treatment of severe insomnia, particularly in situations where falling asleep is difficult or the sleep pattern is severely disturbed.
When ingested orally, the liquid form of Triazolam is absorbed through the gastrointestinal tract. The medication then travels through the bloodstream to the brain, where it binds to GABA (gamma-aminobutyric acid) receptors. GABA is an inhibitory neurotransmitter that reduces neuronal excitability throughout the nervous system. By increasing GABA activity, Triazolam induces sedation, decreases anxiety, and facilitates the onset of sleep. The liquid formulation allows for the medication to be absorbed more quickly than a tablet or capsule, which can be beneficial when a rapid onset of action is desired.
This liquid formulation is particularly useful for patients who have difficulty swallowing pills, such as the elderly or children, or for those with conditions that affect the ability to swallow or digest solid dosage forms. The 0.25 mg/5 mL concentration allows for easy dose adjustments to meet individual patient needs, which is critical given the potency of Triazolam and the importance of tailoring the dose to the patient's specific condition and response to therapy.
It is important to note that Triazolam should only be used for short-term treatment due to the risk of dependence, tolerance, and withdrawal symptoms. It should also be used with caution in certain populations, including those with a history of substance abuse or certain psychiatric conditions. As with all medications, the benefits and risks should be discussed with a healthcare provider.
For patients and prescribers considering the use of Triazolam 0.25 mg/5 mL Oral Liquid, it is essential to understand the medication's pharmacodynamics, appropriate dosing, potential side effects, and the importance of adhering to prescribed treatment regimens. If you have any questions or require further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure appropriate treatment.
Triazolam Oral Liquid is a medication prescribed for treating insomnia, particularly for individuals who have difficulty falling asleep. The liquid format ensures easier administration for those who have trouble swallowing pills.
The medication should be taken exactly as prescribed by your healthcare provider. It is typically taken by mouth, and the dose should be measured using a medical grade syringe or measuring device for accuracy.
This formulation is ideal for patients who find it difficult to swallow tablets or capsules, which includes many pediatric and geriatric patients, or those with dysphagia or other conditions affecting swallowing.
Yes, the oral liquid should be stored at room temperature, away from light and moisture. It is important to keep the medication tightly closed in the container it came in. Do not freeze it, and keep it out of reach of children and pets.
You should follow your healthcare provider's instructions on how to take this medication. Some liquids or foods may interact with the medication, so it's best to take it on its own unless otherwise directed by a healthcare professional.
If you miss a dose of Triazolam Oral Liquid, take it as soon as you remember, unless it's closer to the time of your next dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not double your dose to catch up.
Like all medications, Triazolam can cause side effects. Some common ones include drowsiness, dizziness, headache, memory problems, and coordination issues. If you experience any severe side effects, such as difficulty breathing or signs of an allergic reaction, seek medical attention immediately.
The active ingredient, Triazolam, is the same in both formulations. However, the oral liquid provides a dosing alternative for those who cannot effectively swallow tablets and allows for flexible dose adjustments.
No, you should avoid alcohol consumption while taking Triazolam, as it can increase the sedative effects and might lead to dangerous side effects like respiratory depression and severe drowsiness.
Triazolam is generally not recommended for use during pregnancy due to potential risks to the developing fetus. It is essential to discuss with your healthcare provider if you are pregnant, planning to become pregnant, or if you become pregnant while taking this medication.
The dosing of Triazolam Oral Liquid may need to be adjusted based on the patient's response, tolerance to the medication, and guidance from the healthcare provider. Always consult with a healthcare provider for dose adjustments and do not change your dose without their approval.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
